1. Home
  2. FLGC vs VVOS Comparison

FLGC vs VVOS Comparison

Compare FLGC & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • VVOS
  • Stock Information
  • Founded
  • FLGC 2019
  • VVOS 2016
  • Country
  • FLGC United States
  • VVOS United States
  • Employees
  • FLGC N/A
  • VVOS N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • VVOS Medical Specialities
  • Sector
  • FLGC Health Care
  • VVOS Health Care
  • Exchange
  • FLGC Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • FLGC 17.3M
  • VVOS 18.5M
  • IPO Year
  • FLGC 2021
  • VVOS 2020
  • Fundamental
  • Price
  • FLGC $0.59
  • VVOS $2.63
  • Analyst Decision
  • FLGC Strong Buy
  • VVOS Strong Buy
  • Analyst Count
  • FLGC 4
  • VVOS 2
  • Target Price
  • FLGC $5.67
  • VVOS $6.30
  • AVG Volume (30 Days)
  • FLGC 134.4K
  • VVOS 73.5K
  • Earning Date
  • FLGC 03-24-2025
  • VVOS 05-13-2025
  • Dividend Yield
  • FLGC N/A
  • VVOS N/A
  • EPS Growth
  • FLGC N/A
  • VVOS N/A
  • EPS
  • FLGC N/A
  • VVOS N/A
  • Revenue
  • FLGC $59,505,000.00
  • VVOS $14,581,000.00
  • Revenue This Year
  • FLGC $4.28
  • VVOS $12.35
  • Revenue Next Year
  • FLGC N/A
  • VVOS $26.02
  • P/E Ratio
  • FLGC N/A
  • VVOS N/A
  • Revenue Growth
  • FLGC N/A
  • VVOS 0.54
  • 52 Week Low
  • FLGC $0.59
  • VVOS $1.91
  • 52 Week High
  • FLGC $2.75
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 35.15
  • VVOS 33.05
  • Support Level
  • FLGC $0.59
  • VVOS $3.45
  • Resistance Level
  • FLGC $0.72
  • VVOS $3.36
  • Average True Range (ATR)
  • FLGC 0.05
  • VVOS 0.29
  • MACD
  • FLGC 0.00
  • VVOS -0.05
  • Stochastic Oscillator
  • FLGC 3.85
  • VVOS 9.49

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: